These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 19531)

  • 1. A functional differentiation of human neutrophil granules: generation of C5a by a specific (secondary) granule product and inactivation of C5a by azurophil (primary) granule products.
    Wright DG; Gallin JI
    J Immunol; 1977 Sep; 119(3):1068-76. PubMed ID: 19531
    [No Abstract]   [Full Text] [Related]  

  • 2. The sequential release of granule constitutents from human neutrophils.
    Bentwood BJ; Henson PM
    J Immunol; 1980 Feb; 124(2):855-62. PubMed ID: 6153206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The discharge of primary and secondary granules during immune phagocytosis by normal and chronic granulocytic leukaemia polymorphonuclear neutrophils.
    Maallem H; Sheppard K; Fletcher J
    Br J Haematol; 1982 Jun; 51(2):201-8. PubMed ID: 6952921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils.
    Ward PA; Hill JH
    J Immunol; 1970 Mar; 104(3):535-43. PubMed ID: 4985169
    [No Abstract]   [Full Text] [Related]  

  • 5. Human neutrophil N-acetyl-beta-D-glucosaminidase: granule localization. Further evidence for two azurophil granules.
    West BC; Dunphy CH; Moore CA
    J Lab Clin Med; 1984 Jul; 104(1):60-8. PubMed ID: 6330250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of azurophil and specific granule proteins during differentiation of NB4 cells in neutrophils.
    Grégoire C; Welch H; Astarie-Dequeker C; Maridonneau-Parini I
    J Cell Physiol; 1998 May; 175(2):203-10. PubMed ID: 9525479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a neutrophil chemotactic agent by spermatozoa: role of complement and regulation by seminal plasma factors.
    Clark RA; Klebanoff SJ
    J Immunol; 1976 Oct; 117(4):1378-86. PubMed ID: 977954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil specific granule deficiency.
    Gallin JI
    Annu Rev Med; 1985; 36():263-74. PubMed ID: 3888052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular control of human neutrophil secretion. I. C5a-induced stimulus-specific desensitization and the effects of cytochalasin B.
    Henson PM; Zanolari B; Schwartzman NA; Hong SR
    J Immunol; 1978 Sep; 121(3):851-5. PubMed ID: 211165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement-induced expression of cryptic receptors on the neutrophil surface: a mechanism for regulation of acute inflammation in trauma.
    Solomkin JS; Cotta LA; Ogle JD; Brodt JK; Ogle CK; Satoh PS; Hurst JM; Alexander JW
    Surgery; 1984 Aug; 96(2):336-44. PubMed ID: 6087484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The differential mobilization of human neutrophil granules. Effects of phorbol myristate acetate and ionophore A23187.
    Wright DG; Bralove DA; Gallin JI
    Am J Pathol; 1977 May; 87(2):273-84. PubMed ID: 322507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition by phenytoin of chemotactic factor - stimulated neutrophil functions.
    Webster RO; Goldstein IM; Flick MR
    J Lab Clin Med; 1984 Jan; 103(1):22-33. PubMed ID: 6317777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A monoclonal antibody-inhibiting FMLP-induced chemotaxis of human neutrophils.
    Cotter TG; Keeling PJ; Henson PM
    J Immunol; 1981 Dec; 127(6):2241-5. PubMed ID: 7053244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation.
    Solomkin JS; Jenkins MK; Nelson RD; Chenoweth D; Simmons RL
    Surgery; 1981 Aug; 90(2):319-27. PubMed ID: 7256544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of divalent cations upon complement-mediated enzyme release from human polymorphonuclear leukocytes.
    Goldstein IM; Hoffstein ST; Weissmann G
    J Immunol; 1975 Sep; 115(3):665-70. PubMed ID: 1151072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular and extracellular degranulation of human polymorphonuclear azurophil and specific granules induced by immune complexes.
    Leffell MS; Spitznagel JK
    Infect Immun; 1974 Dec; 10(6):1241-9. PubMed ID: 4215759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunologic release of constituents from neutrophil leukocytes. I. The role of antibody and complement on nonphagocytosable surfaces or phagocytosable particles.
    Henson PM
    J Immunol; 1971 Dec; 107(6):1535-46. PubMed ID: 5120396
    [No Abstract]   [Full Text] [Related]  

  • 18. Complement-dependent platelet and polymorphonuclear leukocyte reactions.
    Henson PM
    Transplant Proc; 1974 Mar; 6(1):27-31. PubMed ID: 4817056
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of rat polymorphonuclear leukocyte subcellular granules.
    Calamai EG; Spitznagel JK
    Lab Invest; 1982 Jun; 46(6):597-604. PubMed ID: 7087390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linkage of azurophil granule secretion in neutrophils to chloride ion transport and endosomal transcytosis.
    Fittschen C; Henson PM
    J Clin Invest; 1994 Jan; 93(1):247-55. PubMed ID: 8282794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.